{
    "root": "0e7d3da8-78fa-b4ae-4a43-15919e900ebe",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "MultiHance",
    "value": "20250314",
    "ingredients": [
        {
            "name": "gadobenate dimeglumine",
            "code": "3Q6PPC19PO"
        }
    ],
    "indications": {
        "text": "magnetic resonance imaging ( mri ) central nervous system ( cns ) adults pediatric patients ( including term neonates ) , visualize lesions abnormal blood-brain barrier abnormal vascularity brain , spine , associated tissues . ( 1.1 ) magnetic resonance angiography ( mra ) evaluate adults known suspected renal aorto-ilio-femoral occlusive vascular disease . ( 1.2 )",
        "doid_entities": [
            {
                "text": "vascular disease (DOID:178)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_178"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended dose multihance 0.2 ml/kg ( 0.1 mmol/kg ) administered rapid bolus intravenous injection . mri cns pediatric patients 2 years age recommended range 0.1 0.2 ml/kg . ensure complete injection contrast medium , follow injection saline flush least 5 ml mri cns least 20 ml mra . ( 2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "16.1 supplied multihance ( gadobenate dimeglumine ) clear , colorless slightly yellow solution containing 529 mg gadobenate dimeglumine per ml . multihance supplied glass vials ; single dose vial rubber stoppered aluminum seal contents sterile . multihance supplied boxes : five 5 ml single dose 10 ml vials ( ndc 0270-5164-12 ) five 10 ml single dose 20 ml vials ( ndc 0270-5164-13 ) five 15 ml single dose 20 ml vials ( ndc 0270-5164-14 ) five 20 ml single dose 20 ml vials ( ndc 0270-5164-15 ) 16.2 storage handling store 25\u00b0c ( 77\u00b0f ) , excursions permitted 15-30\u00b0c ( 59-86\u00b0f ) [ usp controlled room temperature ] . freeze .",
    "adverseReactions": "multihance contraindicated patients known allergic hypersensitivity gadolinium-based contrast agents [ ( 5.3 ) ] .",
    "indications_original": "magnetic resonance imaging (MRI) of the central nervous\nsystem (CNS) in adults and pediatric patients (including term neonates),\nto visualize lesions with abnormal blood-brain barrier or abnormal\nvascularity of the brain, spine, and associated tissues. (1.1) magnetic resonance angiography (MRA) to evaluate adults\nwith known or suspected renal or aorto-ilio-femoral occlusive vascular\ndisease. (1.2)",
    "contraindications_original": "The recommended dose of MultiHance is 0.2 mL/kg (0.1 mmol/kg)\nadministered as a rapid bolus intravenous injection. For MRI of the CNS in pediatric patients below 2 years of\nage the recommended dosage range is 0.1 to 0.2 mL/kg. To ensure complete injection of the contrast medium, follow\nthe injection with a saline flush of at least 5 mL in MRI of the CNS\nand at least 20 mL in MRA. ( 2 )",
    "warningsAndPrecautions_original": "16.1\u2003\u2003How Supplied\n                     MultiHance (gadobenate\ndimeglumine) is a clear, colorless to slightly yellow solution containing\n529 mg gadobenate dimeglumine per mL. MultiHance is supplied in glass\nvials; each single dose vial is rubber stoppered with an aluminum\nseal and the contents are sterile. MultiHance is supplied in boxes\nof:\n                  Five 5 mL single dose 10\nmL vials \u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006(NDC 0270-5164-12)Five 10 mL single\ndose 20 mL vials \u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006(NDC 0270-5164-13)Five 15 mL\nsingle dose 20 mL vials \u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006(NDC 0270-5164-14)Five\n20 mL single dose 20 mL vials \u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006\u2006(NDC 0270-5164-15)\n                  \n                     16.2\u2003\u2003Storage and Handling\n                     Store at 25\u00b0C (77\u00b0F), excursions permitted to 15-30\u00b0C\n(59-86\u00b0F) [see USP Controlled Room Temperature]. Do not freeze.",
    "adverseReactions_original": "MultiHance is contraindicated in patients with known allergic or\nhypersensitivity reactions to gadolinium-based contrast agents [\n                        see Warnings and Precautions (5.3)\n                        \n                     ].",
    "drug": [
        {
            "name": "MultiHance"
        }
    ]
}